Jacobs Levy Equity Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-112,165
Closed -$913K 987
2024
Q3
$913K Sell
112,165
-688,905
-86% -$4.98M ﹤0.01% 737
2024
Q2
$5.12M Buy
801,070
+62,569
+8% +$402K 0.02% 454
2024
Q1
$5.56M Sell
738,501
-5,136
-0.7% -$46.9K 0.02% 408
2023
Q4
$6.89M Sell
743,637
-19,013
-2% -$155K 0.03% 365
2023
Q3
$7.72M Sell
762,650
-271,383
-26% -$3.24M 0.05% 298
2023
Q2
$12.9M Sell
1,034,033
-185,662
-15% -$2.21M 0.07% 247
2023
Q1
$14.2M Sell
1,219,695
-8,794
-0.7% -$112K 0.09% 235
2022
Q4
$13.1M Buy
1,228,489
+690,711
+128% +$6.67M 0.09% 246
2022
Q3
$5.22M Buy
+537,778
New +$7.12M 0.04% 387

Other funds holding HCAT